 Lisdexamfetamine Dimesylate
"Lisdexamfetamine Dimesylate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
| Descriptor ID |
D000069478
|
| MeSH Number(s) |
D02.092.471.683.152.110.200.500
|
| Concept/Terms |
Lisdexamfetamine Dimesylate- Lisdexamfetamine Dimesylate
- Dimesylate, Lisdexamfetamine
- Lis-dexamfetamine Dimesylate
- Dimesylate, Lis-dexamfetamine
- Lis dexamfetamine Dimesylate
|
Below are MeSH descriptors whose meaning is more general than "Lisdexamfetamine Dimesylate".
Below are MeSH descriptors whose meaning is more specific than "Lisdexamfetamine Dimesylate".
This graph shows the total number of publications written about "Lisdexamfetamine Dimesylate" by people in this website by year, and whether "Lisdexamfetamine Dimesylate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lisdexamfetamine Dimesylate" by people in Profiles.
-
Shanmugan S, Loughead J, Nanga RP, Elliott M, Hariharan H, Appleby D, Kim D, Ruparel K, Reddy R, Brown TE, Epperson CN. Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function Difficulties. Neuropsychopharmacology. 2017 01; 42(2):437-445.
-
Epperson CN, Shanmugan S, Kim DR, Mathews S, Czarkowski KA, Bradley J, Appleby DH, Iannelli C, Sammel MD, Brown TE. New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology (Berl). 2015 Aug; 232(16):3091-100.
-
Erder MH, Signorovitch JE, Setyawan J, Yang H, Parikh K, Betts KA, Xie J, Hodgkins P, Wu EQ. Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity. J Med Econ. 2012; 15(6):1078-87.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|